Trial intelligence / Profile preview

Nutren Optimum for Nutritional Support in Nasopharyngeal Carcinoma

NCT03344068Phase 3Unknown

Sponsor
Sun Yat-sen University
Start
Jan 2018
Primary completion
Dec 2020
Countries
1
01

Overview

Phase 3, randomised, open-label trial in nasopharyngeal carcinoma (NPC) and Malnutrition (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Decline in nutritional status needing upgrading nutritional intervention. Status: unknown.

02

Conditions

nasopharyngeal carcinoma (NPC)Malnutrition

Beyond the preview

Go deeper on NCT03344068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03344068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call